European Journal of Clinical Microbiology

, Volume 1, Issue 3, pp 155–158 | Cite as

Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim

  • R. N. Grüneberg
  • A. M. Emmerson
Original Articles
  • 17 Downloads

Abstract

An in vitro technique is described for testing the proposition that combining two antibiotics Prevents the emergence of bacterial resistance to either. The model was applied to testing the combination of sulphamethoxazole and trimethoprim (co-trimoxazole). Under the test conditions when a doubly sensitive organism was exposed to sulphamethoxazole or trimethoprim alone, resistance to sulphamethoxazole or trimethoprim readily emerged. When exposed to both drugs together, the doubly sensitive organism was eliminated from the cultures without emergence of bacterial resistance to either drug. A sulphamethoxazole-resistant organism exposed to trimethoprim alone or to sulphamethoxazole plus trimethoprim developed trimethoprim resistance with equal facility. The experiments show that the use of sulphamethoxazole-trimethoprim prevents the emergence of bacterial resistance among doubly-sensitive strains.

Keywords

Internal Medicine Trimethoprim Bacterial Resistance Sulphamethoxazole Sensitive Organism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bushby, S. R. M., Hitchings, G. H.: Trimethoprim, a sulphonamide potentiator. British Journal of Pharmacology and Chemotherapy 1968, 33: 72–90.Google Scholar
  2. 2.
    Grüneberg, R. N.: The microbiological rationale for the combination of sulphonamides with trimethoprim. Journal of Antimicrobial Chemotherapy 1979, 5 Supplement B: 27–36.Google Scholar
  3. 3.
    Grüneberg, R. N., Emmerson, A. M.: Prevention of emergence of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim. Journal of Antimicrobial Chemotherapy 1980, 6: 349–356.PubMedGoogle Scholar
  4. 4.
    Brumfitt, W., Faiers, M. C., Pursell, R. E., Reeves, D. S., Turnbull, A. R.: Bacteriological, pharmacological and clinical studies with trimethoprimsulphonamide combinations, with particular reference to the treatment of urinary infections. Postgraduate Medical Journal 1969, 45 Supplement: 56–61.PubMedGoogle Scholar
  5. 5.
    Darrell, J. H., Garrod, L. P., Waterworth, P. M.: Trimethoprim: laboratory and clinical studies. Journal of Clinical Pathology 1968, 21: 202–207.PubMedGoogle Scholar
  6. 6.
    Grüneberg, R. N.: Antibiotic sensitivities of urinary pathogens, 1971–1978. Journal of Clinical Pathology 1980, 33: 853–856.PubMedGoogle Scholar
  7. 7.
    Grüneberg, R. N., Emmerson, A. M.: Failure to prevent emergence of bacterial resistance by combination of two antibiotics; fusidic acid and rifampicin. Journal of Antimicrobial Chemotherapy 1980, 6: 562 564.PubMedGoogle Scholar
  8. 8.
    Grüneberg, R. N., Emmerson, A. M.: Prevention of emergence of bacterial resistance. No advantage in combining rifampicin and tetracycline over use of tetracycline alone. Chemotherapy 1981, 27: 188–191.PubMedGoogle Scholar

Copyright information

© Vieweg Publishing 1982

Authors and Affiliations

  • R. N. Grüneberg
    • 1
  • A. M. Emmerson
    • 2
  1. 1.Department of Medical MicrobiologyUniversity College HospitalLondonUK
  2. 2.Department of MicrobiologyWhittington HospitalHighgate Hill, LondonUK

Personalised recommendations